An international, open-label RCT "showed no significant difference in livebirth rates in women with recurrent pregnancy loss and confirmed inherited thrombophilia after treatment with LMWH treatment when compared with standard care alone", write authors.
Research in context ⤵️
ALT Research in context panel.